4
Changes in Ownership
TREACE MEDICAL CONCEPTS, INC. Filed Acc 0001209191-23-030857
Chief Innovation Officer sold 25,000 shares at $25.44 ($635,978)
- Chief Innovation Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Scanlan Sean F. · Chief Innovation Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 1 in the form | +25,000 | $0.10 | $2,500 | 57,395 | D |
| 2023-05-16 | Sale : show line 2 in the form | −25,000 | $25.44 | $635,978 | 32,395 | D |
| Open-market sales · 25,000 sh · avg $25.44 · $635,978 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −25,000 | $0.10 | 2024-12-15 | 25,000 | 33,750 | D |
Loading xslF345X04/doc4.xml…